Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sack

Showing results (181-190 of 245) with videos related to

Pageof 25
Sort By:
American Journal of Respiratory and Critical Care Medicine|July 29, 2017
Occupational Exposures and Subclinical Interstitial Lung Disease. The MESA (Multi-Ethnic Study of Atherosclerosis) Air and Lung StudiesCoralynn S Sack, Brent C Doney, Anna J Podolanczuk, et al.
Journal of Pediatric Surgery|February 16, 2017
Pediatric medical device development by surgeons via capstone engineering design programsBryan S Sack, Rodolfo A Elizondo, Gene O Huang, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Synthesis and biological activity of N-aryl-2-aminothiazoles: potent pan inhibitors of cyclin-dependent kinasesRaj N Misra, Hai-yun Xiao, David K Williams, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor betaJon J Hangeland, Arthur M Doweyko, Tamara Dejneka, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2008
Benzothiazole based inhibitors of p38alpha MAP kinaseChunjian Liu, James Lin, Sidney Pitt, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R)Upender Velaparthi, Mark Wittman, Peiying Liu, et al.
Journal of Medicinal Chemistry|November 7, 2000
Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effectsK S Kim, J S Sack, J S Tokarski, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2020
Discovery of 2,6-difluorobenzyl ether series of phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfones as surprisingly potent, selective and orally bioavailable RORγt inverse agonistsJames J-W Duan, Bin Jiang, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2007
Synthesis and SAR of p38alpha MAP kinase inhibitors based on heterobicyclic scaffoldsT G Murali Dhar, Stephen T Wrobleski, Shuqun Lin, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2008
Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitorsJagabandhu Das, Robert V Moquin, Sidney Pitt, et al.
Pageof 25

Showing results (181-190 of 245) with videos related to

Sort By:
Pageof 25
American Journal of Respiratory and Critical Care Medicine|July 29, 2017
Occupational Exposures and Subclinical Interstitial Lung Disease. The MESA (Multi-Ethnic Study of Atherosclerosis) Air and Lung StudiesCoralynn S Sack, Brent C Doney, Anna J Podolanczuk, et al.
Journal of Pediatric Surgery|February 16, 2017
Pediatric medical device development by surgeons via capstone engineering design programsBryan S Sack, Rodolfo A Elizondo, Gene O Huang, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Synthesis and biological activity of N-aryl-2-aminothiazoles: potent pan inhibitors of cyclin-dependent kinasesRaj N Misra, Hai-yun Xiao, David K Williams, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor betaJon J Hangeland, Arthur M Doweyko, Tamara Dejneka, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2008
Benzothiazole based inhibitors of p38alpha MAP kinaseChunjian Liu, James Lin, Sidney Pitt, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R)Upender Velaparthi, Mark Wittman, Peiying Liu, et al.
Journal of Medicinal Chemistry|November 7, 2000
Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effectsK S Kim, J S Sack, J S Tokarski, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2020
Discovery of 2,6-difluorobenzyl ether series of phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfones as surprisingly potent, selective and orally bioavailable RORγt inverse agonistsJames J-W Duan, Bin Jiang, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2007
Synthesis and SAR of p38alpha MAP kinase inhibitors based on heterobicyclic scaffoldsT G Murali Dhar, Stephen T Wrobleski, Shuqun Lin, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2008
Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitorsJagabandhu Das, Robert V Moquin, Sidney Pitt, et al.
Pageof 25